2ml in a 5ml bottle (Vevye) Wait 30 minutes to instill contact lenses (Miebo) Calcineurin inhibitor immuno- suppressant opthalmic solution (Cequa) Symptomatic Relief in 2 weeks in 2 out of 4 studies (Xiidra) .05% Cyclosporine (Restasis) Money Back Guarantee (Vevye) Throat irritation 13% of patients (Tyrvaya) Symptom Improvement in the first 30 days (Vevye) QID (Miebo) Reduces the signs of dry eye by week 12 in some patients (Xiidra) 1-3% of pts. reported blurred vision and eye redness (Miebo) 95% of patients experienced no or mild installation site pain (Cequa) Ocular burning 17% (Restasis) .03mg of varenicline (Tyrvaya) Installation site reactions 8% (Vevye) Relief from inflammation in the first 15 days (Vevye) The first and only prescription drop that directly targets tear evaporation .09% Cyclosporine (Cequa) Improvement in Schirmer Score at day 28 (Tyrvaya) Available for $79 (Vevye) 65% of central corneas were completely clear at 3 months (Cequa) Patients stay on treatment longer then Restasis and Xiidra (Cequa) When TYRVAYA has not been used for more than 5 days, re- prime with 1 spray into the air Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis) Improvement in visual acuity as early as day 56 (Cequa) Blurred Vision was the most common ocular adverse reaction (Miebo) Fre99.8% of patients reported no or mild stinging/burning (Vevye)e! 30 day supply is 60 .2ml vials (Xiidra) Indicated for the treatment of the signs & symptoms of DED (M, V, T, X) 82% of patients reported sneezing (Tyrvaya) .1% cyclosporine (Vevye) one month supply is 60 .25ml vials (Cequa) Improvement in corneal staining after just 14 days (Cequa) 30-day supply is two 4.2ml bottles (Tyrvaya) 100% perfluorohexy- loctane (Miebo) Lifitegrast 5% (Xiidra) 2ml in a 5ml bottle (Vevye) Wait 30 minutes to instill contact lenses (Miebo) Calcineurin inhibitor immuno- suppressant opthalmic solution (Cequa) Symptomatic Relief in 2 weeks in 2 out of 4 studies (Xiidra) .05% Cyclosporine (Restasis) Money Back Guarantee (Vevye) Throat irritation 13% of patients (Tyrvaya) Symptom Improvement in the first 30 days (Vevye) QID (Miebo) Reduces the signs of dry eye by week 12 in some patients (Xiidra) 1-3% of pts. reported blurred vision and eye redness (Miebo) 95% of patients experienced no or mild installation site pain (Cequa) Ocular burning 17% (Restasis) .03mg of varenicline (Tyrvaya) Installation site reactions 8% (Vevye) Relief from inflammation in the first 15 days (Vevye) The first and only prescription drop that directly targets tear evaporation .09% Cyclosporine (Cequa) Improvement in Schirmer Score at day 28 (Tyrvaya) Available for $79 (Vevye) 65% of central corneas were completely clear at 3 months (Cequa) Patients stay on treatment longer then Restasis and Xiidra (Cequa) When TYRVAYA has not been used for more than 5 days, re- prime with 1 spray into the air Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis) Improvement in visual acuity as early as day 56 (Cequa) Blurred Vision was the most common ocular adverse reaction (Miebo) Fre99.8% of patients reported no or mild stinging/burning (Vevye)e! 30 day supply is 60 .2ml vials (Xiidra) Indicated for the treatment of the signs & symptoms of DED (M, V, T, X) 82% of patients reported sneezing (Tyrvaya) .1% cyclosporine (Vevye) one month supply is 60 .25ml vials (Cequa) Improvement in corneal staining after just 14 days (Cequa) 30-day supply is two 4.2ml bottles (Tyrvaya) 100% perfluorohexy- loctane (Miebo) Lifitegrast 5% (Xiidra)
(Print)
2ml in a 5ml bottle
(Vevye)
Wait 30 minutes to instill contact lenses
(Miebo)
Calcineurin inhibitor immuno-suppressant opthalmic solution (Cequa)
Symptomatic Relief in 2 weeks in 2 out of 4 studies
(Xiidra)
.05% Cyclosporine
(Restasis)
Money Back Guarantee
(Vevye)
Throat irritation
13% of patients
(Tyrvaya)
Symptom Improvement in the first 30 days
(Vevye)
QID
(Miebo)
Reduces the signs of dry eye by week 12 in some patients
(Xiidra)
1-3% of pts. reported blurred vision and eye redness
(Miebo)
95% of patients experienced no or mild installation site pain (Cequa)
Ocular burning 17%
(Restasis)
.03mg of varenicline
(Tyrvaya)
Installation site reactions 8%
(Vevye)
Relief from inflammation in the first 15 days
(Vevye)
The first and only prescription drop that directly targets tear evaporation
.09% Cyclosporine
(Cequa)
Improvement in Schirmer Score at day 28
(Tyrvaya)
Available for $79
(Vevye)
65% of central corneas were completely clear at 3 months
(Cequa)
Patients stay on treatment longer then Restasis and Xiidra
(Cequa)
When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air
Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis)
Improvement in visual acuity as early as day 56
(Cequa)
Blurred Vision was the most common ocular adverse reaction
(Miebo)
Fre99.8% of patients reported no or mild stinging/burning
(Vevye)e!
30 day supply is 60 .2ml vials
(Xiidra)
Indicated for the treatment of the signs & symptoms of DED
(M, V, T, X)
82% of patients reported sneezing
(Tyrvaya)
.1% cyclosporine
(Vevye)
one month supply is 60 .25ml vials
(Cequa)
Improvement in corneal staining after just 14 days
(Cequa)
30-day supply is two 4.2ml bottles
(Tyrvaya)
100% perfluorohexy-loctane
(Miebo)
Lifitegrast 5%
(Xiidra)
